[The choice of a monoclonal antibody (mAb) to distinguish successful therapy from naturally occurring revertant fibres depends on which dystrophin exons are deleted in the DMD patient.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE